PT-141 (bremelanotide) has a half-life of about 2.7 hours, meaning half the drug is eliminated from your bloodstream roughly every 2.5 to 3 hours. The active form of the drug is fully broken down within 24 hours. Its noticeable effects, including changes in blood pressure and sexual response, typically fade within 8 to 10 hours after a dose.
How Quickly PT-141 Peaks and Clears
After a subcutaneous injection, PT-141 reaches its highest concentration in the blood in about 30 minutes. From that peak, levels drop in two phases: a rapid initial decline followed by a slower tail. The average terminal half-life is 2.7 hours, though individual results range from about 1.9 to 4.0 hours.
In practical terms, this means the parent drug (the active molecule itself) is largely gone from your plasma within 12 to 16 hours. But the full picture takes a bit longer. The body breaks PT-141 into smaller amino acid fragments between 4 and 8 hours after the dose, and that conversion is complete by 24 hours. After that point, no pharmacologically active form of the drug remains in circulation.
How the Body Breaks It Down
PT-141 is a small peptide made of seven amino acids, so your body processes it the same way it handles other short protein chains. Enzymes snip the bonds between the amino acids, progressively reducing the molecule to inactive fragments. The final major metabolite is a single amino acid building block called diphenylalanine, which has no drug activity.
About 65% of the drug and its breakdown products are excreted through urine, with another 23% leaving through feces. No intact parent drug shows up in urine, only the inactive fragments. This means the kidneys are the primary exit route, which becomes relevant if you have any degree of kidney impairment.
How Long the Effects Last
The subjective and physiological effects of PT-141 follow a somewhat different timeline than the raw blood levels. Small, transient increases in blood pressure peak within about 4 hours of a dose and return toward baseline by 8 to 10 hours. Most users report that the sexual arousal effects follow a similar window, building within the first hour or two and gradually fading over the following several hours.
This is why the FDA-approved dosing guidelines specify no more than one dose in any 24-hour period and no more than 8 doses per month. Even though the drug itself clears relatively fast, spacing doses at least a full day apart prevents any overlap of physiological effects.
Kidney Function Can Slow Clearance
Because most of PT-141’s metabolites leave through the kidneys, reduced kidney function means the drug stays in your system longer and reaches higher overall levels. People with severe kidney impairment show meaningfully increased systemic exposure, which raises the likelihood and intensity of side effects like nausea. Those with mild to moderate kidney impairment also show somewhat higher drug levels, though not enough to require a dose change in most cases.
Detection After 24 Hours
PT-141 is not part of standard workplace drug panels, which screen for substances like amphetamines, opioids, cannabis, and benzodiazepines. It is, however, a synthetic melanocortin receptor agonist, and specialized anti-doping laboratories can look for peptide hormones if there is reason to test for them.
From a pharmacokinetic standpoint, the active drug converts entirely to inactive metabolites within 24 hours. The metabolites themselves are ordinary amino acid fragments that would be indistinguishable from normal protein digestion products in a routine urine test. For anyone concerned about a standard drug screen, PT-141 is unlikely to trigger a positive result at any point. Specialized peptide testing, if it were performed, would have its best detection window in the first 12 to 24 hours after a dose, when intact drug or early metabolites might still be identifiable.
Timeline Summary
- 30 minutes: Peak blood concentration after injection
- 2.7 hours: Half the drug eliminated (half-life)
- 4 to 8 hours: Active drug is being broken into inactive fragments
- 8 to 10 hours: Physiological effects (blood pressure changes, arousal) return to baseline
- 24 hours: No active drug remains in circulation